{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:31:17Z","timestamp":1784287877551,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202240217"],"award-info":[{"award-number":["202240217"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2306300"],"award-info":[{"award-number":["2023YFC2306300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073802"],"award-info":[{"award-number":["82073802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100723"],"award-info":[{"award-number":["32100723"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972425"],"award-info":[{"award-number":["81972425"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103029"],"award-info":[{"award-number":["82103029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019078","name":"Outstanding Young Talents Funding of Jiangxi Province","doi-asserted-by":"publisher","award":["20192BCBL23025"],"award-info":[{"award-number":["20192BCBL23025"]}],"id":[{"id":"10.13039\/501100019078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.actbio.2025.04.050","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T12:11:00Z","timestamp":1745842260000},"page":"536-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["PCL-PEtOx-based Crystalline-core Micelles for the Targeted Delivery of Paclitaxel and Trabectedin in Ovarian Cancer Therapy"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3865-1779","authenticated-orcid":false,"given":"Zixiu","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8212-4204","authenticated-orcid":false,"given":"Shuli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7009-488X","authenticated-orcid":false,"given":"Chenxu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2949-5436","authenticated-orcid":false,"given":"Qiong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8222-3328","authenticated-orcid":false,"given":"Donglei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3121-3503","authenticated-orcid":false,"given":"Wei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.actbio.2025.04.050_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.050_bib0002","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","article-title":"Drug resistance in ovarian cancer: from mechanism to clinical trial","volume":"23","author":"Wang","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.actbio.2025.04.050_bib0003","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.actbio.2025.04.050_bib0004","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseasedagger","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.actbio.2025.04.050_bib0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/ijgc-2019-000973","article-title":"Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors","volume":"30","author":"Lord","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.actbio.2025.04.050_bib0006","first-page":"304","article-title":"Mechanisms of chemotherapy resistance in ovarian cancer","volume":"5","author":"Ortiz","year":"2022","journal-title":"Cancer Drug Resist"},{"issue":"3","key":"10.1016\/j.actbio.2025.04.050_bib0007","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/cancers16030641","article-title":"The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients","volume":"16","author":"Elyashiv","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.actbio.2025.04.050_bib0008","first-page":"1273","article-title":"Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence","volume":"7","author":"Mascilini","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.actbio.2025.04.050_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114548","article-title":"Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of K(V)1.3 and K(V)1.5 channels","volume":"161","author":"Peraza","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.actbio.2025.04.050_bib0010","doi-asserted-by":"crossref","DOI":"10.4161\/onci.24614","article-title":"Trabectedin: A drug from the sea that strikes tumor-associated macrophages","volume":"2","author":"Allavena","year":"2013","journal-title":"Oncoimmunology"},{"issue":"13","key":"10.1016\/j.actbio.2025.04.050_bib0011","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO.23.01225","article-title":"Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and\/or BRCAness Phenotype: A Randomized Phase III Trial","volume":"42","author":"Lorusso","year":"2024","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.actbio.2025.04.050_bib0012","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3390\/pharmaceutics15112644","article-title":"In Vitro\/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles","volume":"15","author":"Yun","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2025.04.050_bib0013","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.smaim.2022.09.004","article-title":"A pH\/temperature responsive nanocomposite for chemo-photothermal synergistic cancer therapy","volume":"4","author":"Mustafaa","year":"2023","journal-title":"Smart Materials in Medicine"},{"key":"10.1016\/j.actbio.2025.04.050_bib0014","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jconrel.2024.11.005","article-title":"Engineered manganese-BODIPY coordinated nanoadjuvants for enhanced NIR-II photo-metalloimmunotherapy","volume":"376","author":"Zhang","year":"2024","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.050_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202307241","article-title":"Multifunctional Mesoporous Polydopamine-Based Systematic Delivery of STING Agonist for Enhanced Synergistic Photothermal-Immunotherapy","volume":"34","author":"Zeng","year":"2024","journal-title":"Adv Funct Mater"},{"issue":"4","key":"10.1016\/j.actbio.2025.04.050_bib0016","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1021\/acsnano.3c08792","article-title":"An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells","volume":"18","author":"Meng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.04.050_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119420","article-title":"Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer","volume":"222","author":"Peng","year":"2019","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.actbio.2025.04.050_bib0018","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/acs.biomac.2c01481","article-title":"Uniform Two-Dimensional Crystalline Platelets with Tailored Compositions for pH Stimulus-Responsive Drug Release","volume":"24","author":"Zhang","year":"2023","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.actbio.2025.04.050_bib0019","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1021\/nn505068u","article-title":"Homopolymers as structure-driving agents in semicrystalline block copolymer micelles","volume":"9","author":"Rizis","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.04.050_bib0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2018.03.005","article-title":"Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin","volume":"276","author":"Capasso Palmiero","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.actbio.2025.04.050_bib0021","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J Control Release"},{"issue":"43","key":"10.1016\/j.actbio.2025.04.050_bib0022","doi-asserted-by":"crossref","first-page":"25435","DOI":"10.1039\/D0RA02779K","article-title":"Biodegradable reduction and pH dual-sensitive polymer micelles based on poly(2-ethyl-2-oxazoline) for efficient delivery of curcumin","volume":"10","author":"Zhang","year":"2020","journal-title":"RSC Adv"},{"issue":"12","key":"10.1016\/j.actbio.2025.04.050_bib0023","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1016\/j.actbio.2011.07.011","article-title":"Synthesis, characterization and biocompatibility of poly(2-ethyl-2-oxazoline)-poly(D,L-lactide)-poly(2-ethyl-2-oxazoline) hydrogels","volume":"7","author":"Wang","year":"2011","journal-title":"Acta Biomater"},{"issue":"2","key":"10.1016\/j.actbio.2025.04.050_bib0024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2013.08.071","article-title":"Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery","volume":"456","author":"Qiu","year":"2013","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.actbio.2025.04.050_bib0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-3659(03)00162-7","article-title":"Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel","volume":"89","author":"Cheon Lee","year":"2003","journal-title":"J Control Release"},{"issue":"19","key":"10.1016\/j.actbio.2025.04.050_bib0026","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2174\/1381612822666160217125215","article-title":"Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review","volume":"22","author":"Tanbour","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.actbio.2025.04.050_bib0027","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.actbio.2024.01.047","article-title":"A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinoma","volume":"177","author":"Song","year":"2024","journal-title":"Acta Biomaterialia"},{"issue":"10","key":"10.1016\/j.actbio.2025.04.050_bib0028","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/ijc.32343","article-title":"Beyond the tumour microenvironment","volume":"145","author":"Laplane","year":"2019","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.050_bib0029","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13046-024-02981-5","article-title":"Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer","volume":"43","author":"Li","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.050_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43046-022-00143-2","article-title":"CD44(+)\/CD24(-) Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study","volume":"34","author":"Sihombing","year":"2022","journal-title":"J Egypt Natl Canc Inst"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.050_bib0031","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/s41467-022-34191-y","article-title":"Depletion of CD206(+) M2-like macrophages induces fibro-adipogenic progenitors activation and muscle regeneration","volume":"13","author":"Nawaz","year":"2022","journal-title":"Nat Commun"},{"issue":"37","key":"10.1016\/j.actbio.2025.04.050_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202301043","article-title":"Precision Therapy of Recurrent Breast Cancer through Targeting Different Malignant Tumor Cells with a HER2\/CD44-Targeted Hydrogel Nanobot","volume":"19","author":"Chen","year":"2023","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.actbio.2025.04.050_bib0033","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/app.26113","article-title":"Synthesis and characterization of poly(\u03b5-caprolactone)\u2013poly(ethylene glycol) block copolymers prepared by a salicylaldimine-aluminum complex","volume":"105","author":"Du","year":"2007","journal-title":"J Appl Polym Sci"},{"issue":"2","key":"10.1016\/j.actbio.2025.04.050_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008361","article-title":"VCAM1\/VLA4 interaction mediates Ly6Clow monocyte recruitment to the brain in a TNFR signaling dependent manner during fungal infection","volume":"16","author":"Sun","year":"2020","journal-title":"PLoS Pathog"},{"issue":"20","key":"10.1016\/j.actbio.2025.04.050_bib0035","article-title":"Crystallization Behavior of Poly(\u03b5-Caprolactone)-Hollow Glass Microspheres Composites for Rotational Molding Technology","volume":"14","author":"Vignali","year":"2022","journal-title":"Polymers-Basel"},{"issue":"22","key":"10.1016\/j.actbio.2025.04.050_bib0036","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","article-title":"Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor","volume":"67","author":"Xia","year":"2007","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.actbio.2025.04.050_bib0037","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/cells10071647","article-title":"NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells","volume":"10","author":"Liu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.actbio.2025.04.050_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101116","article-title":"Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS\/PI3K signaling-dependent various cytokine production to promote NSCLC growth","volume":"22","author":"Zhang","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.actbio.2025.04.050_bib0039","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.actbio.2025.04.050_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1211068","article-title":"Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity","volume":"14","author":"Povo-Retana","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.actbio.2025.04.050_bib0041","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10637-009-9234-8","article-title":"Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out mice","volume":"28","author":"Beumer","year":"2010","journal-title":"Invest New Drugs"},{"issue":"3","key":"10.1016\/j.actbio.2025.04.050_bib0042","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2019.12.043","article-title":"A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer","volume":"156","author":"Monk","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.actbio.2025.04.050_bib0043","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/1062936X.2024.2337011","article-title":"Prediction of critical micelle concentration for per- and polyfluoroalkyl substances","volume":"35","author":"Creton","year":"2024","journal-title":"SAR QSAR Environ Res"},{"issue":"5","key":"10.1016\/j.actbio.2025.04.050_bib0044","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1310\/hpj4905-425","article-title":"Paclitaxel and Carboplatin (TC) Regimen for Ovarian Cancer","volume":"49","author":"Akin","year":"2014","journal-title":"Hosp Pharm"},{"issue":"9","key":"10.1016\/j.actbio.2025.04.050_bib0045","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s10147-024-02552-w","article-title":"Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models","volume":"29","author":"Kawabata-Iwakawa","year":"2024","journal-title":"Int J Clin Oncol"},{"issue":"24","key":"10.1016\/j.actbio.2025.04.050_bib0046","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2174\/1381612828666220526125806","article-title":"Trabectedin in Cancers: Mechanisms and Clinical Applications","volume":"28","author":"Wang","year":"2022","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.050_bib0047","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.050_bib0048","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12885-024-12577-z","article-title":"Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study","volume":"24","author":"Rubio","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.actbio.2025.04.050_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.102984","article-title":"Tissue-resident macrophages - early passengers or drivers in the tumor niche?","volume":"83","author":"Vogel","year":"2023","journal-title":"Curr Opin Biotechnol"},{"issue":"10","key":"10.1016\/j.actbio.2025.04.050_bib0050","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1084\/jem.20182124","article-title":"Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression","volume":"216","author":"Etzerodt","year":"2019","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.actbio.2025.04.050_bib0051","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","article-title":"Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer","volume":"4","author":"Zheng","year":"2023","journal-title":"Nat Cancer"},{"issue":"11","key":"10.1016\/j.actbio.2025.04.050_bib0052","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.3390\/ijms23116215","article-title":"Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components","volume":"23","author":"Rakina","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.actbio.2025.04.050_bib0053","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin Cell Dev Biol"},{"issue":"22","key":"10.1016\/j.actbio.2025.04.050_bib0054","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","article-title":"Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor","volume":"67","author":"Xia","year":"2007","journal-title":"Cancer Res"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125003034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125003034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:56:45Z","timestamp":1774861005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125003034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"alternative-id":["S1742706125003034"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.04.050","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCL-PEtOx-based Crystalline-core Micelles for the Targeted Delivery of Paclitaxel and Trabectedin in Ovarian Cancer Therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}